| In millions, except per share items | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 |
| | 10-K/A | 10-K/A | 10-K/A | 10-K | 10-K |
| Revenues: |
| Medical Office Buildings | 106.7 | 33.3 | 14.9 | 3.6 | |
| Skilled Nursing Facilities | 49.4 | 34.6 | 10.3 | 1.3 | |
| Hospitals | 23.6 | 10.8 | 6.9 | 1.6 | |
| Senior Housing | 22.5 | 0.9 | | | |
| Other | 2.3 | 21.1 | 8.3 | 2.2 | |
| Total revenues | 204.4 | 100.7 | 40.5 | 8.7 | 0.0 |
| Revenue growth [+] | 102.9% | 149.0% | 366.0% | | |
| Medical Office Buildings | 220.2% | 123.5% | 310.4% | | |
| Skilled Nursing Facilities | 42.8% | 235.8% | 701.9% | | |
| Hospitals | 118.9% | 55.4% | 342.6% | | |
| Senior Housing | 2295.3% | | | | |
| Cost of goods sold | 43.4 | 21.1 | 8.3 | 2.2 | 0.0 |
| Gross profit | 161.0 | 79.6 | 32.1 | 6.5 | 0.0 |
| Gross margin | 78.8% | 79.0% | 79.4% | 74.6% | |
| Selling, general and administrative [+] | 22.5 | 11.1 | 6.0 | 1.7 | 0.3 |
| General and administrative | 22.5 | 11.1 | 6.0 | 1.7 | 0.3 |
| Other operating expenses | | 4.2 | | | |
| EBITDA [+] | 141.0 | 66.6 | 27.8 | 5.1 | |
| EBITDA growth | 111.6% | 139.3% | 441.0% | -2019.8% | |
| EBITDA margin | 69.0% | 66.1% | 68.8% | 59.3% | |
| Depreciation | 50.0 | 25.7 | 11.1 | 2.3 | |
| EBITA | 91.0 | 40.9 | 16.7 | 2.9 | -0.3 |
| EBITA margin | 44.5% | 40.6% | 41.4% | 33.0% | |
| Amortization of intangibles | 28.7 | 15.0 | 5.4 | 1.6 | |
| EBIT [+] | 62.3 | 25.9 | 11.3 | 1.2 | -0.3 |
| EBIT growth | 140.7% | 128.9% | 827.0% | -555.2% | |
| EBIT margin | 30.5% | 25.7% | 28.0% | 14.1% | |
| Non-recurring items | 25.5 | 75.6 | 10.4 | 7.1 | 0.0 |
| Interest expense, net [+] | 17.8 | 13.6 | 6.3 | 1.4 | 0.0 |
| Interest expense | 18.1 | 13.6 | 6.3 | 1.4 | |
| Interest income | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 |
| Other income (expense), net [+] | -11.0 | 0.0 | -0.4 | -0.1 | |
| Gain (loss) on debt retirement | | 4.2 | | | |
| Gain (loss) on derivative instruments | | | | -0.1 | |
| Gain (loss) on foreign currency transactions | -11.3 | | | | |
| Pre-tax income | 8.1 | -63.2 | -5.8 | -7.4 | -0.3 |
| Income taxes | -1.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | 0.0% | 0.0% | | 0.4% |
| Minority interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net income | 9.1 | -63.2 | -5.8 | -7.4 | -0.3 |
| Net margin | 4.4% | -62.8% | -14.3% | -85.5% | |
| |
| Basic EPS [+] | $0.05 | ($0.85) | ($0.19) | ($0.99) | ($1.52) |
| Growth | -105.3% | 355.4% | -81.1% | -34.6% | |
| Diluted EPS [+] | $0.05 | ($0.85) | ($0.19) | ($0.99) | ($1.52) |
| Growth | -105.3% | 355.4% | -81.1% | -34.6% | |
| |
| Dividends per share [+] | $0.29 | $0.31 | $0.30 | $0.28 | |
| Growth | -6.9% | 1.8% | 8.9% | | |
| |
| Shares outstanding (basic) [+] | 199.8 | 74.1 | 30.8 | 7.5 | 0.2 |
| Growth | 169.5% | 140.6% | 312.4% | 3909.7% | |
| Shares outstanding (diluted) [+] | 199.8 | 74.1 | 30.8 | 7.5 | 0.2 |
| Growth | 169.5% | 140.6% | 312.4% | 3909.7% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |